# | Title | Journal | Year | Citations |
---|
1 | Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk | Country Review Ukraine | 2006 | 135 |
2 | Reassessing treatment of acute heart failure syndromes: the ADHERE Registry | Country Review Ukraine | 2005 | 109 |
3 | The role of HDL-cholesterol in preventing atherosclerotic disease | Country Review Ukraine | 2005 | 88 |
4 | What is the relationship between risk factor reduction and degree of weight loss? | Country Review Ukraine | 2005 | 81 |
5 | The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction | Country Review Ukraine | 2006 | 67 |
6 | Introduction to the metabolic syndrome | Country Review Ukraine | 2005 | 60 |
7 | Bleeding and management of bleeding | Country Review Ukraine | 2006 | 60 |
8 | The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients | Country Review Ukraine | 2005 | 57 |
9 | Testing antiplatelet therapy | Country Review Ukraine | 2008 | 46 |
10 | Premature withdrawal and alternative therapies to dual oral antiplatelet therapy | Country Review Ukraine | 2006 | 43 |
11 | Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe | Country Review Ukraine | 2005 | 41 |
12 | Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target? | Country Review Ukraine | 2005 | 41 |
13 | Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism | Country Review Ukraine | 2006 | 39 |
14 | Model of chronic adaptation: right ventricular function in Eisenmenger syndrome | Country Review Ukraine | 2007 | 39 |
15 | Heart rate: an independent risk factor in cardiovascular disease | Country Review Ukraine | 2007 | 38 |
16 | From individual risk factors and the metabolic syndrome to global cardiometabolic risk | Country Review Ukraine | 2008 | 38 |
17 | Reviewing the reality: why we need to change | Country Review Ukraine | 2005 | 35 |
18 | Blood pressure is the most important cause of death and disability in the world | Country Review Ukraine | 2007 | 35 |
19 | Resistance to antiplatelet drugs | Country Review Ukraine | 2006 | 34 |
20 | Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association | Country Review Ukraine | 2007 | 34 |
21 | Epidemiology of low HDL-cholesterol: results of studies and surveys | Country Review Ukraine | 2006 | 31 |
22 | Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk | Country Review Ukraine | 2008 | 30 |
23 | Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseases | Country Review Ukraine | 2007 | 28 |
24 | Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes | Country Review Ukraine | 2006 | 27 |
25 | How should we assess right ventricular function in 2008? | Country Review Ukraine | 2007 | 27 |
26 | The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors | Country Review Ukraine | 2005 | 25 |
27 | The follow-up of cardiac devices: what to expect for the future? | Country Review Ukraine | 2007 | 25 |
28 | Aetiology and consequences of the metabolic syndrome | Country Review Ukraine | 2005 | 24 |
29 | Right ventricular function in pulmonary hypertension: physiological concepts | Country Review Ukraine | 2007 | 24 |
30 | Evolution of pacing for bradycardias: sensors | Country Review Ukraine | 2007 | 23 |
31 | Evolution of pacing for bradycardia: Autocapture | Country Review Ukraine | 2007 | 22 |
32 | Low-gradient ‘severe’ aortic stenosis with preserved ejection fraction: new entity, or discrepant definitions? | Country Review Ukraine | 2008 | 22 |
33 | Clinical application of the natriuretic peptides in heart failure | Country Review Ukraine | 2006 | 21 |
34 | Hypertension, society, and public policy | Country Review Ukraine | 2007 | 21 |
35 | Pressure overload-induced right ventricular dysfunction and remodelling in experimental pulmonary hypertension: the right heart revisited | Country Review Ukraine | 2007 | 21 |
36 | Pharmacology of thienopyridines: rationale for dual pathway inhibition | Country Review Ukraine | 2006 | 20 |
37 | Dyslipidaemia and global cardiovascular risk: clinical issues | Country Review Ukraine | 2006 | 20 |
38 | The QT interval as it relates to the safety of non-cardiac drugs | Country Review Ukraine | 2007 | 20 |
39 | New developments in oral antiplatelet therapy | Country Review Ukraine | 2007 | 20 |
40 | A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor | Country Review Ukraine | 2008 | 20 |
41 | Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy | Country Review Ukraine | 2005 | 19 |
42 | History of electrical therapy for the heart | Country Review Ukraine | 2007 | 19 |
43 | Niaspan®: creating a new concept for raising HDL-cholesterol | Country Review Ukraine | 2005 | 17 |
44 | International Day for the Evaluation of Abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries | Country Review Ukraine | 2006 | 17 |
45 | Beta-blockade in CHF: from contraindication to indication | Country Review Ukraine | 2006 | 17 |
46 | Reducing risk by raising HDL-cholesterol: the evidence | Country Review Ukraine | 2006 | 17 |
47 | When and how to discontinue antiplatelet therapy | Country Review Ukraine | 2008 | 16 |
48 | The realities of dyslipidaemia: what do the studies tell us? | Country Review Ukraine | 2005 | 15 |
49 | Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension | Country Review Ukraine | 2007 | 15 |
50 | Implantable cardioverter defibrillators: from evidence of trials to clinical practice | Country Review Ukraine | 2007 | 15 |